• 2 months 3 weeks ago Help us improve our website: http://t.co/vY9vRzmYRH! Please take our visitor survey: http://t.co/8gY0wRZtGx. Thank you...
  • 2 months 3 weeks ago 1st European Research Forum on Healthy Ageing: 03 Sept in Bxl. Policy makers, scientists, industrials: save the date! http://t.co/6TXrBI5rdt
  • 3 months 4 days ago Gender inequalities in health: a matter of policies according to @sophieproject http://t.co/TzwZzXko3g
  • 4 months 1 day ago 1/3 of cancer patients killed by 'fat-burning' process termed cachexia, @CNIO_Cancer researchers say http://t.co/GjfipsdG2R
  • 4 months 4 weeks ago New EU research project @pneumonp aims to tackle antibiotic resistance via inhalable nano therapeutics #nanomedicine http://t.co/VQN9WHojG2
  • 5 months 2 weeks ago Urban renewal improves the health of neighbours in Barcelona according to EU-funded project @sophieproject http://t.co/F0mKCdPBZ5
  • 5 months 2 weeks ago Check this article on #CommHERE: how to spread the word about research and reach out beyond the scientific community http://t.co/VDcKVDEfcc
  • 6 months 2 weeks ago Scientists @CNIO_Cancer among the 40 most important global researchers http://t.co/Rc0hIsq6dN
  • 6 months 3 weeks ago 2nd workshop @CIBER_ISCIII to strengthen the EU‐LAC Health Research Cooperation http://t.co/93qLQObcQj
  • 8 months 2 weeks ago The European Symposium in Drug Synthesis @unisiena will take place on May 18-23. You can register until April 15!! http://t.co/V8kxQIev9S

SyStemAge

Portrait of Dr. Anne-Claude Gavin, European Project Coordinator

Dr Anne-Claude Gavin

Scientific Coordinator of SyStemAge, based at European Molecular Biology Laboratory (EMBL) Heidelberg, Germany

Research field

Stem Cells, Ageing

If you like this
If you want to know more
Research Profile

Who?

“Collaborating with scientists from very different research fields is a constant source of curiosity, inspiration and motivation for me”, says Anne-Claude Gavin. Dr Gavin’s work has been awarded the Heidelberg Molecular Life Sciences Investigator Award for Genome Technology and the All-Stars Award ‘Most Prolific in Proteomics’.

Why?

Age-related diseases are a growing health concern worldwide. “We aim to determine the involvement of stem cells in the onset and development of two age-related disorders called ‘myelodysplastic syndrome’ and ‘B-cell chronic lymphocytic leukaemia’. In this way, we are paving the way for innovative treatment options.”

What?

“Stem cells can become different types of cells. They are crucial to tissue repair. They also support body functions that need to adapt quickly, e.g. the immune system. Ageing disrupts the regenerative function of stem cells. This increases a person’s risk of cancer and chronic inflammation. We aim to understand this process.”

How?

“The complexity of biological systems calls for scientists with different fields of expertise to team up to achieve common goals”, says Dr Gavin. The SyStemAge project brings together scientists with experience that ranges from basic research to designing treatment options. Together, they can improve the health of the elderly.

A living organism is as old as its stem cells

In the Picture
In the Picture
Image credits

Background image: SyStemAge

Portrait of the project coordinator: SyStemAge

Timeline (in chronological order): 1914: Peter Wolbert, The University of Wurzburg; 1994: Nature Publishing Group; 1997: Wikimedia; 2006: Associated Press